United Kingdom · Venture startup

Who invested in Creo Medical

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2014, from 2 sources

$5.5MSeed$8.4MVenture
Latest round
Venture, $8.4MSept 2015
Step-upi
1.5×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015
$5.5MSeed$8.4MVenture
First round
Seed, $5.5M
Nov 2014
Biggest round
$8.4M
Venture · Sept 2015
Between rounds
10 months
from the last two

The rounds

  1. Sept 2015
    Venture$8.4M1 new2 returning

    From a historical funding record

  2. Nov 2014
    Seed$5.5M2 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

ACF InvestorsVC firm2rounds
Finance WalesInvestment firm2rounds
Pentax MedicalInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Creo Medical

Who invested in Creo Medical?

Creo Medical's investors include ACF Investors, Finance Wales and Pentax Medical.

How much has Creo Medical raised?

Creo Medical has raised $14M across 2 rounds since 2014.

When did Creo Medical last raise?

Creo Medical's most recent round was a Venture of $8.4M in Sept 2015.

What was Creo Medical's biggest round?

Its most recent round, $8.4M in Sept 2015, is also its largest on record.

Who backed Creo Medical first?

Creo Medical's first round on record, in Nov 2014, was backed by ACF Investors and Finance Wales.

What stage is Creo Medical at?

Creo Medical's latest named round is a Venture, in Sept 2015.

Where is Creo Medical based?

Creo Medical is based in the United Kingdom.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.